Overview of Acute Repetitive Seizures MarketThe global Acute Repetitive Seizures Market is valued at USD 3.2 Billion in 2024 ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets ...

All three can be given in one visit, usually at no cost under federal rules and private-insurance coverage. If you’re unsure ...

Experts warn against the risks of diphenhydramine, suggesting safer alternatives for allergy relief with fewer side effects ...

The legal battle over the scope of orphan drug exclusivity continues, as the U.S. Food and Drug Administration (“FDA”) has recently lost a second ...

Since NeuroStar was the first TMS manufacturer to receive FDA clearance as an add-on therapy to treat adolescents, ages 15-21, with major depressive disorder in March 2024, we have seen over a ...

While fear of needles is still holding back many vaccination campaigns, science is preparing the next generation: an ...

The spray treats inflammation in the brain and reduces it so that the patient's thinking and memory will no longer deteriorate.

The Wiest family tells Action News Jax they first got Neffy, a nasal spray treatment for severe allergies, after it was ...

Intranasal insulin, delivered through a nasal spray, can safely and effectively reach critical brain areas tied to memory in older adults, marking a key advance toward potential treatments for ...

Oxygen deprivation around birth can lead to brain damage in babies, with far-reaching consequences. A new stem cell treatment ...